These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 658781)

  • 21. The kinin-forming enzyme system in pregnancy and obstetrical DIC.
    Maki M; Soga K; Gotoh K
    Bibl Haematol; 1983; (49):239-46. PubMed ID: 6421272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor.
    Silverberg M; Longo J; Kaplan AP
    J Biol Chem; 1986 Nov; 261(32):14965-8. PubMed ID: 3639874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
    Bock PE; Shore JD; Tans G; Griffin JH
    J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats.
    Katori M; Majima M; Odoi-Adome R; Sunahara N; Uchida Y
    Br J Pharmacol; 1989 Dec; 98(4):1383-91. PubMed ID: 2692754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein.
    Kerbiriou DM; Bouma BN; Griffin JH
    J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prekallikrein, HMW-kininogen and factor XII in various disease states.
    Deutsch E; Dragosics B; Kopsa H; Mannhalter C; Rainer H
    Thromb Res; 1983 Jul; 31(2):351-64. PubMed ID: 6356459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatic protein synthesis of the kallikrein-kininogen-kinin system].
    Adam A; Reynaert M; Damas P; Ers P; Boulanger J; Roeseler J; Faymonville ME; Lamy M; Damas J
    Presse Med; 1988 Feb; 17(4):151-4. PubMed ID: 2964610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Physiological and pathological significance of plasma prekallikrein in obstetrics].
    Soga K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1763-72. PubMed ID: 6924684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma kallikrein activation and inhibition during typhoid fever.
    Colman RW; Edelman R; Scott CF; Gilman RH
    J Clin Invest; 1978 Feb; 61(2):287-96. PubMed ID: 74379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen.
    Scicli AG; Mindroiu T; Scicli G; Carretero OA
    J Lab Clin Med; 1982 Jul; 100(1):81-93. PubMed ID: 6919569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers.
    DeLa Cadena RA; Suffredini AF; Page JD; Pixley RA; Kaufman N; Parrillo JE; Colman RW
    Blood; 1993 Jun; 81(12):3313-7. PubMed ID: 7685203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of plasmin activity, plasminogen levels and activity of antiplasmins during endotoxin shock in dogs.
    Aasen AO; Gallimore MJ; Ohlsson K; Amundsen E
    Haemostasis; 1978; 7(2-3):164-9. PubMed ID: 77807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New congenital deficiency of high molecular weight kininogen and prekallikrein (Fitzgerald trait). Study of response to DDAVP and venous occlusion.
    Vicente V; Alberca I; Gonzalez R; Alegre A; Redondo C; Moro J
    Haematologia (Budap); 1986; 19(1):41-8. PubMed ID: 3636267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
    Schapira M; Scott CF; Colman RW
    Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of components of the plasma kallikrein-kinin system during experimental lung insufficiency in dogs.
    Saugstad OD; Aasen AO; Guldvog I; Lium B; Lyngaas K; Amundsen E
    Acta Chir Scand Suppl; 1982; 509():61-7. PubMed ID: 6962621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation.
    Bouma BN; Kerbiriou DM; Vlooswijk RA; Griffin JH
    J Lab Clin Med; 1980 Oct; 96(4):693-709. PubMed ID: 6903191
    [No Abstract]   [Full Text] [Related]  

  • 40. Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase.
    Claeson G; Friberger P; Knös M; Eriksson E
    Haemostasis; 1978; 7(2-3):76-8. PubMed ID: 26629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.